Latest Regulatory Approval News

Tivan Limited has received regulatory clearance to begin drilling at its Sandover Fluorite Project, aiming to unlock high-grade fluorite deposits with assays reaching 94% CaF2. The staged drilling program marks a significant step toward defining a commercially viable resource.

The ASX has granted key waivers allowing Southern Cross Media to proceed with its acquisition of Seven West Media without shareholder approval, smoothing the way for a major media consolidation.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.

Talga Group and SQM have mutually terminated their joint venture for the Aero Project in Sweden due to regulatory delays, with Talga now exploring new partnership opportunities to advance the critical minerals project.

Santana Minerals has taken a major step forward by acquiring freehold ownership of critical lands and extinguishing royalties at its Bendigo-Ophir Gold Project, enhancing project economics amid a strong gold market.

Firebrick Pharma has secured a $102,000 investment from its Philippines strategic partner, Pharma Nutria N.A., Inc., reinforcing its position ahead of the Nasodine nasal spray launch in 2026.

Anteris Technologies has secured its first European regulatory clearance to commence the global PARADIGM Trial for its DurAVR Transcatheter Heart Valve, marking a significant step toward worldwide commercialization.

Clarity Pharmaceuticals has inked a pivotal supply agreement with Nusano to ensure a steady source of copper-67, a critical isotope for its upcoming Phase III prostate cancer trial and future commercialisation plans.

Moho Resources has reported new high-grade gold assays up to 6.98g/t at its Bush Chook Project in Western Australia, extending a mineralised trend to 300 metres and setting the stage for a maiden drill program later this year or early next.

EMVision Medical Devices’ latest Share Purchase Plan has attracted applications exceeding its initial $1 million target, with limited oversubscription capacity remaining ahead of the October 23 closing date.

Provaris Energy has launched a Robotics Innovation Centre in Norway, marking a pivotal step in fabricating and testing advanced hydrogen and liquid CO2 storage tanks. The initiative aims to accelerate prototype completion and commercial scalability by early 2026.

Blue Star Helium Limited is advancing its Galactica helium project in Colorado, aiming for initial commercial production by December 2025, supported by a recent A$4.5 million equity raise.